Clinical Trial: Written Exposure in Substance Treatment (WEST 3.0): Randomized Controlled Trial

U.S., Aug. 25 -- ClinicalTrials.gov registry received information related to the study (NCT07782268) titled 'Written Exposure in Substance Treatment (WEST 3.0): Randomized Controlled Trial' on Aug. 12.

Brief Summary: The purpose of the current research study is to evaluate the efficacy of the refined Written Exposure in Substance Treatment (WEST) for PTSD among residential SUD patients through a randomized controlled trial. All participants meet criteria for PTSD and are in a short term residential SUD treatment program (target residential treatment duration = 28 days) regardless of the research. Participants will be randomly assigned to WEST + treatment as usual (TAU) or TAU only. The primary outcome is change in PTSD symptoms from pre-in...